跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

300116S

Avanti

Control (5mL vial)

Avanti Polar Lipids

登录查看公司和协议定价

别名:
Control (Pegylated Liposomal Vehicle), frozen liposomal suspension (buffer - 10% w/w sucrose, 10 mM histidine ~pH 6.5)
UNSPSC代码:
12352211
NACRES:
NA.25

检测方案

>99% (HPLC/MS)

形式

solution

包装

pkg of 1 × 5 mL (300116S-1EA)

制造商/商品名称

Avanti Polar Lipids

应用

vaccine development

运输

dry ice

储存温度

−20°C

一般描述

Formulation: A Pegylated, long-circulating liposomal formulation with an ammonium sulfate core. Liposomes are stored frozen for a longer shelf life.

应用

Control (5mL vial) has been used as a control for doxorubicin Hcl product (Dox2) to study its characteristics by asymmetrical-flow field flow fractionation (MD-AF4). It may be used as a vehicle control liposome for liposomal encapsulated doxorubicin (Dox-NP).

包装

10 mL clear serum vial (300116S-1EA)

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation
Parot J, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society (2020)
J Parot et al.
Journal of controlled release : official journal of the Controlled Release Society, 320, 495-510 (2020-02-01)
Liposomal formulations for the treatment of cancer and other diseases are the most common form of nanotechnology enabled pharmaceuticals (NEPs) submitted for market approval and in clinical application today. The accurate characterization of their physical-chemical properties is a key requirement;

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门